MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 07 05 2019
revised: 04 07 2019
accepted: 02 08 2019
pubmed: 23 8 2019
medline: 30 5 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

Overexpression of the serine/threonine kinase GLK/MAP4K3 in human lung cancer is associated with poor prognosis and recurrence, however, the role of GLK in cancer recurrence remains unclear. Here, we report that transgenic GLK promotes tumor metastasis and cell migration through the scaffold protein IQ motif-containing GTPase-activating protein 1(IQGAP1). GLK transgenic mice displayed enhanced distant metastasis. IQGAP1 was identified as a GLK-interacting protein; two proline-rich regions of GLK and the WW domain of IQGAP1 mediated this interaction. GLK and IQGAP1 colocalized at the leading edge including filopodia and lamellipodia of migrating cells. GLK directly phosphorylated IQGAP1 at Ser-480 enhancing Cdc42 activation and subsequent cell migration. GLK-induced cell migration and lung cancer metastasis were abolished by IQGAP1 depletion. Consistently, human NSCLC patient tissues displayed increased phospho-IQGAP1, which correlated with poor survival. Collectively, GLK promotes lung cancer metastasis by binding to, phosphorylating, and activating IQGAP1. SIGNIFICANCE: These findings show the critical role of the GLK-IQGAP cascade in cell migration and tumor metastasis, suggesting it as a potential biomarker and therapeutic target for lung cancer recurrence.

Identifiants

pubmed: 31431460
pii: 0008-5472.CAN-19-1402
doi: 10.1158/0008-5472.CAN-19-1402
doi:

Substances chimiques

IQ motif containing GTPase activating protein 1 0
ras GTPase-Activating Proteins 0
MAP4K3 protein, human EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4978-4993

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Huai-Chia Chuang (HC)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Chih-Chi Chang (CC)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Chiao-Fang Teng (CF)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Chia-Hsin Hsueh (CH)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Li-Li Chiu (LL)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Pu-Ming Hsu (PM)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.

Ming-Ching Lee (MC)

Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.

Chung-Ping Hsu (CP)

Division of Thoracic Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.

Yi-Rong Chen (YR)

Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan.

Yi-Chung Liu (YC)

Institute of Population Sciences, National Health Research Institutes, Zhunan, Taiwan.

Ping-Chiang Lyu (PC)

Institute of Bioinformatics and Structural Biology, National Tsing-Hua University, Hsinchu, Taiwan.

Tse-Hua Tan (TH)

Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan. ttan@nhri.edu.tw.
Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH